Instructions to Authors  by unknown
The Editorial Board requires authors to be in compliance with the Uniform 
Requirements for Manuscripts Submitted to Biomedical Journals (URMs), 
which are compiled by the International Committee of Medical Journal 
Editors (ICMJE); current URMs are available at www.icmje.org.
 These Instructions to Authors are revised periodically by the Editors as 
needed. Authors should consult a recent issue of the Journal or visit 
www.ap-smart.com for the latest version of these instructions. Any manu-
script not prepared according to these instructions will be returned immedi-
ately to the author(s) without review.
1. Manuscript Submission
1.1. Online Submission
Manuscripts (meaning all submission items, including all text, tables, art-
work, cover letter, conflicts of interest disclosures, and any other required 
documents/material) must be submitted online to AP-SMART through the 
Elsevier Editorial System (EES) at http://ees.elsevier.com/apsmart. If 
assistance is required, please refer to the tutorials for authors and/or cus-
tomer support that are available on the EES website; you may also contact 
the Editorial Office. Please do not post, fax or e-mail your manuscripts to 
the Editorial Office.
Editorial Office
Asia-Pacific Journal of Sports Medicine, Arthroscopy, 
Rehabilitation and Technology
Room 74029, 5/F, Clinical Sciences Building
Department of Orthopaedics and Traumatology
Prince of Wales Hospital, Shatin, New Territories
Hong Kong SAR
Tel: (+852) 2646-4555
Fax: (+852) 2646-3020
E-mail: apsmarteditorial@ort.cuhk.edu.hk
1.2. Important Information
l
  Articles should be in Microsoft Word document format and prepared in 
the simplest form possible. We will add in the correct font, font size, 
margins and so on according to the Journal’s style.
l
  You may use automatic page numbering, but do NOT use other kinds of 
automatic formatting such as footnotes, headers and footers. References 
especially should NOT be formatted using the MS Word “endnotes” or 
“footnotes” function; instead, you may use the commercially available 
EndNote® or Reference Manager® software to manage your references.
l
  Put text, references, table headings and tables, and figure legends in one 
file.
l
  Figures must be submitted as separate picture files, at the correct 
resolution and named according to the figure number and format, e.g., 
“Fig1.tif”, “Fig2.jpg”. Please see section 9.8 for more information.
1.3. Supporting Documents
The following documents must be included in your submission (refer 
also to the Checklist that follows these author instructions). Items (1), 
(2) and (3) are mandatory. Items (4), (5), (6) and (7) are required only if 
they are applicable to your manuscript.
(1)  Cover Letter. This must include the following information: 
•	 title of the manuscript
•	  names (spelled out in full) of all the authors*, and the 
institutions with which they are affiliated; indicate all 
affiliations with a superscripted lowercase letter after the 
author’s name and in front of the matching affiliation (*the 
name of each author should be written with the family name 
last, e.g., Yuen-Lam Cheung)
•	  corresponding author details (name, e-mail, mailing address, 
telephone and fax numbers)
•	  a statement that the material contained in the manuscript has 
not been previously published and is not being concurrently 
submitted elsewhere
•	  persons who do not fulfill the requirements to be listed as 
authors but who nevertheless contributed to the manuscript 
(such as those who provided writing assistance, for example) 
should be disclosed
•	  list of manuscripts that have been published, submitted, or 
are in press that are similar to the submission to AP-SMART 
(and include in your submission copies of those similar 
manuscripts so that AP-SMART Editors can be assured there 
is no overlap)
•	 the signature of the corresponding author
•	  Optional: if you have a list of reviewers who you wish to 
review or not to review your manuscript, you may include 
this list in the cover letter
(2)  Authorship & Conflicts of Interest Statement. Each author’s contri-
bution to the manuscript should be listed. Any and all potential and 
actual conflicts of interest should also be listed (see Section 2 for 
more information). Please use the AP-SMART Authorship & 
Conflicts of Interest Statement form that follows these author instruc-
tions and that is also provided on the Journal’s website at www.ap-
smart.com. Your signature and those of ALL your coauthors must be 
included.
(3)  Copyright Transfer Agreement. In the event that your manuscript is 
accepted for publication in AP-SMART, you are required to transfer all 
copyright ownership in and relating to the work to APKASS. Please 
use the AP-SMART Copyright Transfer Agreement form that follows 
these author instructions and that is also provided on the Journal’s 
website at www.ap-smart.com. Your signature and those of ALL your 
coauthors must be included.
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(4)  Ethics Statement. Articles covering the use of human or animal sam-
ples in research, or human or animal experiments must be accompa-
nied by a letter of approval from the relevant review committee or 
authorities. See Section 3 for more information.
(5)  Consolidated Standards of Reporting Trials (CONSORT) flow chart 
for randomized controlled trials submitted for publication. See Section 
4 for more information.
(6)  Signed Statement of Informed Consent. Articles where human sub-
jects can be identified in descriptions, photographs or pedigrees 
must be accompanied by a signed statement of informed consent to 
publish (in print and online) the descriptions, photographs and ped-
igrees from each subject who can be identified. See Section 5 for 
more information.
(7)  Copyright Permission. If you have reproduced or adapted material 
from other copyrighted sources, the letter(s) of permission from the 
copyright holder(s) to reproduce or adapt the copyrighted sources 
must be supplied. Otherwise, such material must be removed from 
your manuscript.
2. Disclosure of Conflicts of Interest
A conflict of interest occurs when an individual’s objectivity is poten-
tially compromised by a desire for financial gain, prominence, pro-
fessional advancement or a successful outcome. AP-SMART Editors 
strive to ensure that what is published in the Journal is as balanced, 
objective and evidence-based as possible. Since it can be difficult to 
distinguish between an actual conflict of interest and a perceived con-
flict of interest, the Journal requires authors to disclose all and any 
potential conflicts of interest.
Conflicts of interest may be financial or non-financial. Financial 
conflicts include financial relationships such as honoraria; education-
al grants; participation in speakers’ bureaus; membership, employ-
ment, consultancies, stock ownership, or other equity interest; expert 
testimony or patent-licensing arrangements. Non-financial conflicts 
include personal or professional relationships, affiliations, academic 
competition, intellectual passion, knowledge or beliefs that might af-
fect objectivity.
Please ensure that the name of each author listed in your man-
uscript appears in either Section I or Section II on page 2 of the 
AP-SMART Authorship & Conflicts of Interest Statement form (an 
author’s name cannot appear in both Section I and Section II of the 
form).
3. Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations, appropriate institu-
tional review board or ethics committee approval is required, and such 
approval should be stated in the methods section of the manuscript. 
For those investigators who do not have formal ethics review commit-
tees, the principles outlined in the Declaration of Helsinki should be 
followed (World Medical Association. Declaration of Helsinki: ethi-
cal principles for medical research involving human subjects. Avail-
able at: www.wma.net/en/30publications/10policies/b3/17c.pdf).
For investigation of human subjects, state explicitly in the meth-
ods section of the manuscript that informed consent was obtained 
from all participating adult subjects and from parents or legal guard-
ians for minors or incapacitated adults, together with the manner in 
which informed consent was obtained (e.g., oral or written).
For work involving animals, the guidelines for their care and use 
that were followed should be stated in the methods section of the 
manuscript. For those investigators who do not have formal institu-
tional guidelines relating to animal experiments, the European Com-
mission Directive 86/609/EEC for animal experiments (available at 
http://ec.europa.eu/environment/chemicals/lab_animals/legislation_ 
en.htm) should be followed and the same should be stated in the 
methods section of the manuscript.
4. Reporting Clinical Trials
All randomized controlled trials submitted for publication should 
include a completed Consolidated Standards of Reporting Trials 
(CONSORT) flow chart (please go to www.consort-statement.org for 
more information). AP-SMART has adopted the ICMJE proposal that 
requires, as a condition of consideration for publication of clinical 
trials, registration in a public trials registry. Trials must register at or 
before the onset of patient enrollment. The clinical trial registration 
number should be included at the end of the abstract of the article.
For this purpose, a clinical trial is defined as any research study 
that prospectively assigns human participants or groups of humans 
to one or more health-related interventions to evaluate the effects 
of health outcomes. Health-related interventions include any inter-
vention used to modify a biomedical or health-related outcome (for 
example drugs, surgical procedures, devices, behavioral treatments, 
dietary interventions, and process-of-care changes). Health outcomes 
include any biomedical or health-related measures obtained in pa-
tients or participants, including pharmacokinetic measures and ad-
verse events.
Purely observational studies (those in which the assignment of 
the medical intervention is not at the discretion of the investigator) 
will not require registration. Further information can be found at 
www.icmje.org.
5. Identification of Patients in Descriptions, Photographs 
and Pedigrees
A signed statement of informed consent to publish (in print and on-
line) patient descriptions, photographs and pedigrees should be ob-
tained from all persons (parents or legal guardians for minors) who 
can be identified (including by the patients themselves) in such writ-
ten descriptions, photographs or pedigrees. Such persons should be 
shown the manuscript before its submission. Omitting data or making 
data less specific to de-identify patients is acceptable, but changing 
any such data is not acceptable. State explicitly in the methods section 
of the manuscript that informed consent was obtained from all par-
ticipating adult subjects or from parents or legal guardians for minors 
or incapacitated adults, together with the manner in which informed 
consent was obtained (i.e., oral or written).
6. Previous Publication or Duplicate Submission
Submitted manuscripts are considered with the understanding that 
they have not been published previously in print or electronic format 
(except in abstract or poster form) and are not under consideration in 
totality or in part by another publication or electronic medium.
7. Basic Criteria
Articles should be written in English, using British English spelling, 
and meet the following basic criteria: the material is original, the 
information is important, the writing is clear and concise, the study 
methods are appropriate, the data are valid, and the conclusions are 
reasonable and supported by the data.
8. Article Categories
The categories of articles that are published in the Journal are listed 
and described below. Please select the category that best describes 
your paper. If your paper does not fall into any of these categories, 
please contact the Editorial Office.
8.1. Original Articles
These articles typically include randomized trials, intervention stud-
ies, studies of screening and diagnostic tests, laboratory and animal 
studies, cohort studies, cost-effectiveness analyses, case-control stud-
ies, and surveys with high response rates, which represent new and 
significant contributions to sports medicine. They should include an 
abstract and be structured as follows: Abstract, Introduction, Materi-
als and Methods, Results, Discussion, Conflicts of Interest Statement 
(if any), Acknowledgements (if any), References, Figures and Tables 
(if any), and Supplementary Material (if any).
The Introduction should provide a brief background to the subject 
of the paper, explain the importance of the study, and state a precise 
study question or purpose.
The Materials and Methods section should describe the study 
design and methods (including the study setting and dates, patients/
participants with inclusion and exclusion criteria, patient samples or 
animal specimens used, the essential features of any interventions, 
the main outcome measures, the laboratory methods followed, or data 
sources and how these were selected for the study), and state the sta-
tistical procedures employed in the research.
The Results section should comprise the study results presented in a 
logical sequence, supplemented by tables and/or figures. Take care that 
the text does not repeat data that are presented in tables and/or figures. 
Only emphasize and summarize the essential features of the main results.
The Discussion section should be used to emphasize the new and 
important aspects of the study, placing the results in context with pub-
lished literature, the implications of the findings, and the conclusions 
that follow from the study results. The text is limited to 6000 words 
and not more than 40 references.
8.2. Review Articles
These should provide a balanced synthesis of current knowledge on 
areas such as sports medicine, arthroscopy, rehabilitation, sports tech-
nology, reconstructive surgery and upper limb. Reviews can be up to 
6000 words in length. They should have a short pithy title, an abstract 
of not more than 100 words, not more than 80 references and up to 4 
figures/tables. While reviews are usually submitted by invitation only, 
unsolicited reviews will also be given due consideration.
8.3. Case Reports
These are short discussions of a case or case series with unique fea-
tures not previously described that make an important teaching point 
or scientific observation. They may describe novel techniques or use 
of equipment, or new information on diseases of importance. Section 
headings should be: Abstract, Introduction, Case Report, Discussion, 
Conflicts of Interest Statement (if any), Acknowledgements (if any), 
and References.
The Introduction should describe the purpose of the present 
report, the significance of the disease and its specificity, and briefly 
review the relevant literature.
The Case Report should include the general data of the case, 
medical history, family history, chief complaint, present illness, 
clinical manifestation, methods of diagnosis and treatment, and 
outcome.
The Discussion should compare, analyse and discuss the simi-
larities and differences between the reported case and similar cases 
reported in other published articles. The importance or specificity of 
the case should be restated when discussing the differential diagnoses. 
Suggest the prognosis of the disease and possibility of prevention.
8.4. Editorials
These are usually written by invited authors or editorial board mem-
bers and are comments on recent news or articles published in the 
Journal. Editorials should be no longer than 1000 words with no 
more than 5 references. A photograph of the author(s) is required for 
illustration.
8.5. Perspectives
Perspectives discuss one or several papers recently published in AP-
SMART or other journals that present key findings in the specific 
subject with views from both the basic and clinical perspectives and 
relevance to patient care.
Perspectives are limited to 4000 words (including abstract, main 
text, references and figure legends). They should have a concise title, 
an abstract of 50 words or less, no more than 35 references, and 1 or 
2 figures (with figure legends) or tables.
Summary of the requirements of the different article categories
Original Article Review Article Case Report Editorial Perspective Letter to the 
Editor
Word count 6000 6000 1200 1000 4000 1000
Abstract  
(word count)
Yes (500) Yes (100) Yes (500) No Yes (50) No
No. of references 40 80 10 5 35 10
No. of figures/
tables
8 4 No limit No 2 2
Author photo & No No No Yes Optional No
description
8.6. Letters to the Editor
Letters provide readers with an opportunity to raise issues of interest 
to the sports medicine community or to respond to an article previ-
ously published in AP-SMART. Letters should provide new informa-
tion or a fresh perspective on the previously published articles.
Letters should begin with “Dear Editor”, be less than 1000 words, 
with not more than 10 references and 2 figures/tables. Letters are sent 
to the author(s) of the previously published article under discussion 
for their response.
9. Manuscript Preparation
Text should be typed double-spaced on white A4 (297 ¥ 210 mm) 
paper, with outer margins of 2.5 cm. The manuscript should include a 
title page, abstract, keywords, main text, conflicts of interest statement 
(if any), acknowledgements (if any), references, and figures and tables 
as appropriate. Each section of the manuscript should begin on a new 
page. Pages should be numbered consecutively, beginning with the title 
page.
9.1. Title Page
The title page should contain the following information (in order, 
from the top to bottom of the page):
•	 article	category
•	 article	title
•	 	IMPORTANT: please do NOT include any author names and affili-
ations or corresponding author information on the title page (this 
information should be listed in your cover letter instead) because 
AP-SMART follows a double-blind peer review process
9.2. Abstracts and Keywords
An unstructured abstract (i.e., in one single paragraph with no sub-
headings) and 3–5 relevant keywords (in alphabetical order) are re-
quired for the following article categories: Original Articles, Review 
Articles, Case Reports and Perspectives. The word count limits for 
abstracts should follow the requirements listed in the summary table 
in Section 8 of these Instructions to Authors.
The abstract should state briefly the purpose of the research, the 
principal results and major conclusions. An abstract is often presented 
separately from the article, so it must be able to stand alone. For this 
reason, References should be avoided, but if essential, then cite the 
author(s) and year(s). Also, non-standard or uncommon abbreviations 
should be avoided, but if essential they must be defined at their first 
mention in the abstract itself.
Keywords will be used for indexing purposes and should be taken 
from the Medical Subject Headings (MeSH) list of Index Medicus 
(www.nlm.nih.gov/mesh/meshhome.html). Avoid general and plural 
terms and multiple concepts (avoid, for example, “and”, “of”). Be 
sparing with abbreviations: only abbreviations firmly established in 
the field may be eligible.
No abstract or keywords are required for Editorials and Letters 
to the Editor.
9.3. Main Text
The text for Original Articles should be organized into the following 
sections: Introduction, Materials and Methods, Results, Discussion, 
Conflicts of Interest Statement (if any), Acknowledgements (if any), 
and References. Sections for Case Reports are: Introduction, Case 
Report, Discussion, Conflicts of Interest Statement (if any), Acknowl-
edgements (if any), and References. Each section should begin on a 
new page.
9.3.1. Abbreviations
Where a term/definition will be continually referred to, it must be writ-
ten in full when it first appears in the text, followed by the subsequent 
abbreviation in parentheses. Thereafter, the abbreviation may be used. 
An abbreviation should not be first defined in any section heading; if an 
abbreviation has previously been defined in the text, then the abbrevia-
tion may be used in a subsequent section heading. Restrict the number 
of abbreviations to those that are absolutely necessary.
9.3.2. Numbers
Numbers that begin a sentence or those that are less than 10 should be 
spelled out using letters. Centuries and decades should be spelled out, 
e.g., the Eighties or nineteenth century. Laboratory parameters, time, 
temperature, length, area, mass, and volume should be expressed us-
ing digits.
9.3.3. Units
Système International (SI) units must be used, with the exception of 
blood pressure values which are to be reported in mmHg. Use the 
metric system for the expression of length, area, mass, and volume. 
Temperatures are to be given in degrees Celsius.
9.3.4. Names of drugs, devices and other products
Use the Recommended International Non-proprietary Name (rINN) 
for medicinal substances, unless the specific trade name of a drug is 
directly relevant to the discussion. Generic drug names should appear 
in lowercase letters in the text. If a specific proprietary drug needs to 
be identified, the brand name may appear only once in the manuscript 
in parentheses following the generic name the first time the drug is 
mentioned in the text.
For devices and other products, the specific brand or trade name, 
the manufacturer and their location (city, state, country) should be 
provided the first time the device or product is mentioned in the text, 
for example, “…IBM SPSS Statistics 21.0 was used (IBM Corp., 
Armonk, NY, USA)”. Thereafter, the generic term (if appropriate) 
should be used.
9.3.5. Gene nomenclature
Current standard international nomenclature for genes should be 
adhered to. For human genes, use genetic notation and symbols 
approved by the HUGO Gene Nomenclature Committee (www.
genenames.org). You may also refer to the resources available on 
PubMed at www.ncbi.nlm.nih.gov/guide/genes-expression. The Hu-
man Genome Variation Society has a useful site that provides guid-
ance in naming mutations at www.hgvs.org/mutnomen/index.html. In 
your manuscript, genes should be typed in italic font and include the 
accession number.
9.3.6. Statistical requirements
Statistical analysis is essential for all research papers. Use correct 
nomenclature for statistical methods (e.g., two sample t test, not un-
paired t test). Descriptive statistics should follow the scales used in 
data description. Inferential statistics are important for interpreting 
results and should be described in detail.
All p values should be presented to the third decimal place for 
accuracy. The smallest p value that should be expressed is p < 0.001 
since additional zeros do not convey useful information; the largest p 
value that should be expressed is p > 0.99.
9.3.7. Personal communications and unpublished data
These sources cannot be included in the references list but may be de-
scribed in the text. The author(s) must give the full name and highest 
academic degree of the person, the date of the communication, and 
indicate whether it was in oral or written (letter, fax, e-mail) form. A 
signed statement of permission should be included from each person 
identified as a source of information in a personal communication or 
as a source for unpublished data.
9.4. Conflicts of Interest Statement and/or Funding/Support 
Statement
Since it is difficult to distinguish between an actual conflict of interest 
and a perceived conflict of interest, AP-SMART requires authors to dis-
close all and any potential conflicts of interest and let readers judge for 
themselves. Therefore, please ensure that you provide information about 
any potential financial and non-financial conflicts of interest (see Sec-
tion 2 for more information) in a concise paragraph after the main text.
All financial and material support for the research, work, writing 
and editorial assistance from internal or external agencies, including 
commercial companies, should be clearly and completely identified 
in a Funding/Support Statement.
9.4.1. Special note to reviewers
Reviewers form the cornerstone of the peer-review process, and their 
evaluations ensure the quality of published research. Therefore, the 
Editors seek reviewers for AP-SMART who do not have conflicts of 
interest with the reported research in the manuscripts.
9.5. Acknowledgements
After the Conflicts of Interest Statement and/or Funding/Support 
Statement, general acknowledgements for consultations and statisti-
cal analyses should be listed concisely, including the names of the 
individuals who were directly involved. Consent should be obtained 
from those individuals before their names are listed in this section. 
Those acknowledged should not include secretarial, clerical or tech-
nical staff whose participation was limited to the performance of their 
normal duties.
9.6. References
Authors are responsible for the accuracy and completeness of their 
references and for correct in-text citation.
9.6.1. In the main text, tables and figure legends
•	 	References	 should	 be	 indicated	 by	 superscripted	Arabic	 numer-
als, numbered consecutively in order of appearance. The numerals 
should be placed outside periods and commas, and inside colons 
and semicolons. [The actual authors can be referred to, but the ref-
erence number(s) must always be given.]
•	 	References	cited	in	tables	or	figure	legends	should	be	included	in	
sequence at the point where the table or figure is first mentioned in 
the main text.
•	 	Do	not	cite	abstracts	unless	they	are	the	only	available	reference	to	
an important concept.
•	 	Do	not	cite	uncompleted	work	or	work	 that	has	not	yet	been	ac-
cepted for publication (i.e., “unpublished observation”, “personal 
communication”) as references. Also see Section 9.3.7.
9.6.2. In the references list
•	 	References	should	be	compiled	at	the	end	of	the	manuscript	accord-
ing to the order of citation in the text.
•	 	References	should	be	limited	to	those	cited	in	the	text	only.
•	 	Journal	references	should	include,	in	order,	authors’	surnames	and	
initials, article title, abbreviated journal name, year, volume and 
inclusive page numbers.
•	 	The	surnames	and	initials	of	all	the	authors	up	to	6	should	be	in-
cluded, but when authors number 7 or more, list the first 3 authors 
only followed by “et al”.
•	 	Abbreviations	for	journal	names	should	conform	to	those	used	in	
MEDLINE.
•	 	If	 citing	 a	 website,	 provide	 the	 author	 information,	 article	 title,	
website address and the date you accessed the information.
•	 	Reference	to	an	article	that	is	in	press	must	state	the	journal	name	
and, if possible, the year and volume.
Examples of the most common reference types are provided below. 
(Please pay particular attention to the formatting, word capitalization, 
spacing and style.)
Standard journal article
Aerts I, Cumps E, Verhagen E, Verschueren J, Meeusen R. A system-
atic review of different jump-landing variables in relation to injuries. 
J Sports Med Phys Fitness. 2013;53:509–519.
Journal supplement
Kaplan NM. The endothelium as prognostic factor and therapeu-
tic target: what criteria should we apply? J Cardiovasc Pharmacol. 
1998;32(suppl 3):S78–S80.
Journal article not in English but with English abstract
Kawai H, Ishikawa T, Moroi J, et al. Elderly patient with cerebel-
lar malignant astrocytoma. No	Shinkei	Geka. 2008;36:799–805. [In 
Japanese, English abstract]
Book with edition
Bradley EL. Medical and Surgical Management. 2nd ed. Philadel-
phia: Saunders; 1982.
Book with editors
Letheridge S, Cannon CR, eds. Bilingual Education: Teaching Eng-
lish as a Second Language. New York: Praeger; 1980.
Book chapter in book with editor and edition
Greaves M, Culligan DJ. Blood and bone marrow. In: Underwood 
JCE, ed. General	and	Systematic	Pathology. 4th ed. London: Church-
ill Livingstone; 2004:615–672.
Book series with editors
Wilson JG, Fraser FC, eds. Handbook of Teratology, Vols. 1–4. New 
York: Plenum Press; 1977–1978.
Bulletin
World Health Organization. World Health Report 2002: Reducing 
Risk, Promoting Healthy Life. Geneva, Switzerland: World Health 
Organization; 2002.
Company/manufacturer publication/pamphlet
Eastman Kodak Company, Eastman Organic Chemicals. Catalog	No.	
49. Rochester, NY: Eastman Kodak; 1977:2–3.
Electronic publications
Duchin JS. Can preparedness for biological terrorism save us from 
pertussis? Arch Pediatr Adolesc Med. 2004;158:106–107. Available 
from: http://archpedi.ama-assn.org/cgi/content/full/158/2/106. 
Accessed June 12, 2004.
Smeeth L, Iliffe S. Community screening for visual impairment 
in the elderly. Cochrane Database Syst Rev. 2002(2):CD001054. 
doi:10.1002/14651858.CD1001054.
Items presented at a meeting but not yet published
Durbin D, Kallan M, Elliott M. Risk of injury to restrained children 
from passenger air bags. Paper presented at: 46th Annual Meeting 
of the Association for the Advancement for Automotive Medicine; 
September 2002; Tempe, AZ.
Greenspan A, Eerdekens M, Mahmoud R. Is there an increased rate 
of cerebrovascular events among dementia patients? Poster presented 
at: 24th Congress of the Collegium Internationale Neuro-Psychophar-
macologicum (CINP); June 20–24, 2004; Paris, France.
Khuri FR, Lee JJ, Lippman SM. Isotretinoin effects on head and neck 
cancer recurrence and second primary tumors. In: Proceedings from 
the American Society of Clinical Oncology; May 31–June 3, 2003; 
Chicago, IL. Abstract 359.
Item presented at a meeting and published
Cionni RJ. Color perception in patients with UV- or bluelight-filtering 
IOLs. In: Symposium on Cataract, IOL, and Refractive Surgery. San 
Diego, CA: American Society of Cataract and Refractive Surgery; 
2004. Abstract 337.
Material accepted for publication but not yet published
Carrau RL, Khidr A, Crawley JA. The impact of laryngopharyngeal 
reflux on patient-reported quality of life. Laryngoscope. In press.
Ofri D. Incidental Findings: Lessons from my Patients in the Art of 
Medicine. Boston, MA: Beacon Press. In press.
Theses and dissertations
Undeman C. Fully Automatic Segmentation of MRI Brain Images Us-
ing Probabilistic Diffusion and a Watershed Scale–Space Approach 
[master’s thesis]. Stockholm, Sweden: NADA, Royal Institute of 
Technology; 2001.
Ayers AJ. Retention of Resin Restorations by Means of Enamel Etch-
ing and by Pins [MSD thesis]. Indianapolis: Indiana University; 1971.
Website
American Association of Oral and Maxillofacial Surgeons. Wisdom 
Teeth. AAOMS Web site. http://www.aaoms.org/wisdom_teeth.php. 
Accessed November 15, 2012.
9.7. Tables
Tables should supplement, not duplicate, the text. They should have 
a concise table heading, be self-explanatory, and numbered consecu-
tively in the order of their citation in the text. Items requiring ex-
planatory footnotes should be denoted using superscripted lowercase 
letters (a, b, c, etc.), with the footnotes arranged under the table in 
alphabetical order. Asterisks (*, **) are used only to indicate the 
probability level of tests of significance. Abbreviations used in the 
table must be defined and placed after the footnotes in alphabetical 
order. If you include a block of data or table from another source, 
whether published or unpublished, you must acknowledge the origi-
nal source.
9.8. Figures
9.8.1. General guidelines
The number of figures should be restricted to the minimum neces-
sary to support the textual material. Figures should have an informa-
tive figure legend and be numbered in the order of their citation in the 
text. All symbols and abbreviations should be defined in the figure 
legend in alphabetical order. Items requiring explanatory footnotes 
should follow the same style as that for tables as described in Sec-
tion 9.7.
Unless you have written permission from the patient (or, where 
applicable, the next of kin), the personal details (such as their name 
and date of birth) of the patient must be removed. If their face is 
shown, use a black bar to cover their eyes so that they cannot be iden-
tified (for further information, see www.elsevier.com/patientphoto-
graphs).
All lettering should be done professionally and should be in pro-
portion to the drawing, graph or photograph. Photomicrographs must 
include an internal scale marker, and the legend should state the type 
of specimen, original magnification and stain.
Figures must be submitted as separate picture files, at the cor-
rect resolution (see Section 9.8.2.) and named according to the figure 
number and format, e.g., “Fig1.tif”, “Fig2.jpg”.
9.8.2. Formats
Regardless of the application used, when your electronic artwork is 
finalized, please “save as” or convert the images to one of the fol-
lowing formats (note the resolution requirements for line drawings, 
halftones, and line/halftone combinations given below):
l
  EPS: vector drawings. Embed the font or save the text as “graph-
ics”.
l
  TIFF: colour or greyscale photographs (halftones)—use a mini-
mum of 300 dpi.
l
  TIFF: bitmapped line drawings—use a minimum of 1000 dpi.
l
  TIFF: combination of bitmapped line/halftone (colour or greys-
cale)—use a minimum of 600 dpi.
l
  DOC, XLS or PPT: if your electronic artwork is created in any of 
these Microsoft Office applications, please supply “as is”.
Please do not:
l
  Supply files that do not meet the resolution requirements detailed 
above;
l
  Supply files that are optimized for screen use (such as GIF, BMP, 
PICT, WPG) as the resolution is too low;
l
  Submit graphics that are disproportionately large for the content.
A detailed guide on electronic artwork is available at http://www.
elsevier.com/artworkinstructions. 
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